PTCT – ptc therapeutics, inc. (US:NASDAQ)
Stock Stats
News
PTC Therapeutics (PTCT) was upgraded by Raymond James Financial, Inc. to "moderate buy".
PTC Therapeutics (PTCT) is now covered by Raymond James Financial, Inc.. They set an "outperform" rating and a $108.00 price target on the stock.
How The PTC Therapeutics (PTCT) Story Is Shifting With Sephience And DMD Uncertainty [Yahoo! Finance]
PTC Therapeutics (PTCT) had its "hold" rating reaffirmed by Jefferies Financial Group Inc.. They now have a $76.00 price target on the stock, down from $91.00.
PTC Therapeutics (PTCT) was upgraded by Truist Financial Corporation to "strong-buy".
Form 4 PTC THERAPEUTICS, INC. For: Apr 06 Filed by: Boulding Mark Elliott
Form 4 PTC THERAPEUTICS, INC. For: Apr 02 Filed by: Golden Lee Scott
Form 144 PTC THERAPEUTICS, INC. Filed by: Boulding Mark Elliott
Form 4 PTC THERAPEUTICS, INC. For: Apr 01 Filed by: Almstead Neil Gregory
Form 144 PTC THERAPEUTICS, INC. Filed by: Golden Lee Scott
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.